Abeona Therapeutics Inc.
ABEO
$5.40
-$0.01-0.09%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 103.00% | -22.16% | |||
| Gross Profit | 12.22% | 16.64% | |||
| SG&A Expenses | -2.75% | 12.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.96% | 3.56% | |||
| Operating Income | 4.61% | -5.38% | |||
| Income Before Tax | -1.56% | -116.37% | |||
| Income Tax Expenses | 98.59% | -197.97% | |||
| Earnings from Continuing Operations | -296.43% | -104.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -296.43% | -104.74% | |||
| EBIT | 4.61% | -5.38% | |||
| EBITDA | 5.82% | -5.22% | |||
| EPS Basic | -289.59% | -104.59% | |||
| Normalized Basic EPS | 0.26% | 29.63% | |||
| EPS Diluted | -270.50% | -105.86% | |||
| Normalized Diluted EPS | 0.26% | 10.73% | |||
| Average Basic Shares Outstanding | 1.80% | 3.27% | |||
| Average Diluted Shares Outstanding | 1.80% | -18.60% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||